Code I26: A Precise Tool to Strengthen VTE Surveillance
RPTH Journal (Research and Practice in Thrombosis and Haemostasis) shared an insightful post on LinkedIn:
”Current ICD codes make it difficult to track venous thrombosis incidence in real time. This original article suggests use of “I26″ which has high specificity for VTE in the Unite States, and may help capture the incidence of PE.
Authors: Jeffrey Kline, Jesse Wrenn, Alexis Drinkhorn, Mazin Alam, Steven Korzeniewski, Christopher Kabrhel”
Read the full article here.
Accurately tracking venous thromboembolism (VTE) incidence in real time remains a challenge with current ICD coding.
In the article ”Diagnostic accuracy of the international classification of disease ‘I26’ code to detect acute pulmonary embolism in a surveillance network” by Jeffrey Kline et al. published in RPTH Journal, the potential of using the ”I26” code is discussed.
This study highlights the potential of using the ICD code “I26”, which demonstrates high specificity for VTE in the United States, particularly for capturing pulmonary embolism cases.
Implementing this approach may improve surveillance and inform public health strategies!
For deeper insights and the latest research, be sure to read Hemostasis Today.
-
Sep 5, 2025, 14:06Thrombosis Update: VTE Death Rate 3X Higher in Los Angeles Jails Than General Population
-
Sep 4, 2025, 22:00Shivani Modi Highlights SOHO 2025 Study Linking Elevated WBC Counts to Increased Thrombosis Risk
-
Sep 4, 2025, 22:00Cancer, Clots and Communication: Register Now for The Upcoming Webinar on CAT!
-
Sep 4, 2025, 11:52PARTHENOPE Trial: A New Benchmark in Risk Score Validation
-
Sep 4, 2025, 09:46SOHO 2025: Exploring AI in Hematology and Oncology
-
Sep 5, 2025, 14:04Melasma Treatment Advances: Non-Ablative Laser and Tranexamic Acid Combination Explained
-
Sep 5, 2025, 12:55RENOVE and API-CAT Trials: Exploring Secondary VTE Prevention
-
Sep 5, 2025, 12:18Lucia Masarova Presents Results of Phase III SURPASS-ET Trial at SOHO 2025: Ropeg's Efficacy for Essential Thrombocythemia
-
Sep 5, 2025, 06:28Digital Twin Study Predicts Higher Thrombotic Recurrence with DOACs vs VKAs in APS Patients
-
Sep 4, 2025, 22:00Asfand Yar Cheema at SOHO 2025: PSM Cohort Study on GLP-1 Agonist Therapy Key Clinical Outcomes for Polycythemia Vera
-
Sep 2, 2025, 13:53Cost-Effective Strategies to Reduce Anaemia Highlighted in The Lancet Haematology
-
Sep 2, 2025, 13:04Ischemic Stroke or TIA Linked to Higher Femoral Fracture Risk
-
Sep 2, 2025, 12:51Treatment of Deep Brain AVMs Tied to Increased Hemorrhagic Stroke Risk
-
Aug 29, 2025, 09:03Vasculearn Network: New 2025 High Blood Pressure Guidelines Are Here
-
Aug 18, 2025, 23:56Dr. Arun V. J Invites You to His Lecture on ‘AI and Data Sciences in Transfusion Medicine’ at the AI in Healthcare Conclave. Register now!
-
Sep 5, 2025, 14:12EAHAD Podcast: Reducing Pain and Distress in Children Receiving Emicizumab
-
Sep 5, 2025, 03:18Pier Mannuccio Mannucci on How Green Spaces and Physical Activity Can Help Prevent Heart Failure
-
Sep 5, 2025, 02:15Abdul Mannan Explains How DOACs Can Confuse Lupus Anticoagulant Testing
-
Sep 4, 2025, 11:55Sumyea Kabir Highlights the Critical Role of Safe Donors in Blood Transfusion Safety
-
Sep 3, 2025, 14:18Living with Factor V Deficiency: Helen’s Inspiring Story on Haemnet Haemcast